IP Verse

Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof

Patent No. EP4342987 (titled "Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof") was filed by Toolgen Incorporated on Oct 23, 2013. The application was issued on Mar 18, 2026.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
VERTEX PHARMACEUTICALS INCORPORATEDFeb 4, 2026CARPMAELS & RANSFORD
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBFeb 4, 2026VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP4342987

TOOLGEN INCORPORATED
Application Number
EP23183112A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
Jan 1, 2026
Publication Date
Mar 18, 2026
External Links
Slate, Register , Google Patents